1307231-02-2 Usage
Description
(R)-4-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride is a chemical compound that serves as a hydrochloride salt of a secondary amine featuring a bromine atom attached to a dihydroindene ring. It is widely recognized for its utility in organic synthesis and pharmaceutical research, offering unique properties and reactivity that make it an indispensable tool for chemists and researchers in the domain of drug discovery and medicinal chemistry.
Uses
Used in Pharmaceutical Research:
(R)-4-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride is utilized as a key intermediate in the development of new medications, leveraging its structural features to contribute to the creation of innovative pharmaceutical agents.
Used in Organic Synthesis:
In the field of organic synthesis, (R)-4-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride is employed as a building block for the synthesis of complex organic molecules, capitalizing on its reactivity to facilitate the construction of diverse chemical entities.
Used in Drug Discovery:
(R)-4-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride is harnessed as a valuable tool in drug discovery, where its unique properties aid in the identification and optimization of potential therapeutic agents, thereby advancing the development of novel treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1307231-02-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,0,7,2,3 and 1 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1307231-02:
(9*1)+(8*3)+(7*0)+(6*7)+(5*2)+(4*3)+(3*1)+(2*0)+(1*2)=102
102 % 10 = 2
So 1307231-02-2 is a valid CAS Registry Number.
1307231-02-2Relevant articles and documents
PYRIMIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE
-
Paragraph 00184; 00185, (2013/10/22)
The present invention provides compounds of Formula (I), as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicaments.
